혈액 유래 병원균 검출 시장 보고서(2026년)

Direct-from-blood pathogen detection is a diagnostic method that identifies infectious agents such as bacteria, viruses, or fungi directly from a patient's blood sample without the need for prior culture. It helps to enable rapid, accurate detection of bloodstream infections, sepsis, or other systemic infections, allowing timely treatment decisions and improved patient outcomes. This approach reduces diagnostic delays, lowers the risk of complications, and supports more targeted antimicrobial therapy.

The primary technology types of direct-from-blood pathogen detection include polymerase chain reaction (PCR)-based, next-generation sequencing, immunoassay, mass spectrometry, and other technologies. PCR-based methods amplify and detect pathogen DNA or RNA directly from blood samples for rapid and accurate diagnosis. They are applied to bacterial, viral, fungal, and parasitic pathogens. Applications include sepsis, bloodstream infections, hospital-acquired infections, and others, serving end users such as hospitals, diagnostic laboratories, research institutes, and other sectors.

Tariffs on imported diagnostic reagents, sequencing kits, and laboratory instruments are impacting the direct-from-blood pathogen detection market by increasing costs for PCR kits, NGS platforms, and mass spectrometry equipment. Regions such as North America, Europe, and Asia-Pacific that depend on imported molecular diagnostics tools are most affected. While tariffs raise operational expenses, they also encourage local manufacturing of diagnostic kits, stimulate regional R&D investments, and drive innovation in cost-effective pathogen detection technologies, supporting long-term market resilience.

The direct-from-blood pathogen detection market research report is one of a series of new reports from The Business Research Company that provides direct-from-blood pathogen detection market statistics, including direct-from-blood pathogen detection industry global market size, regional shares, competitors with a direct-from-blood pathogen detection market share, detailed direct-from-blood pathogen detection market segments, market trends and opportunities, and any further data you may need to thrive in the direct-from-blood pathogen detection industry. This direct-from-blood pathogen detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The direct-from-blood pathogen detection market size has grown rapidly in recent years. It will grow from $1.72 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing incidence of bloodstream infections, rising demand for rapid diagnostics, growth of hospital and clinical laboratory infrastructure, technological advances in molecular diagnostics, increasing awareness of antimicrobial resistance.

The direct-from-blood pathogen detection market size is expected to see rapid growth in the next few years. It will grow to $3.09 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing adoption of digital and automated pathogen detection platforms, increasing use of multiplex PCR and targeted sequencing, rising demand for point-of-care rapid diagnostics, expansion of hospital and diagnostic laboratory networks in emerging markets, increasing focus on personalized antimicrobial therapy. Major trends in the forecast period include rising adoption of rapid pcr-based diagnostics, increasing use of next-generation sequencing for pathogen detection, expansion of mass spectrometry applications in clinical labs, growing implementation of immunoassay-based detection systems, rising focus on microfluidic and biosensor technologies.

The increasing prevalence of infectious diseases is expected to drive the expansion of the direct-from-blood pathogen detection market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms that invade and proliferate within the body, with the potential to spread to others. The rise in infectious diseases is linked to urbanization, as higher population density in cities facilitates faster transmission of pathogens through close human contact and shared resources. Direct-from-blood pathogen detection supports the identification of infectious diseases by enabling rapid, sensitive, and precise detection of pathogens directly from blood samples. This approach reduces diagnostic delays, informs timely treatment decisions, and enhances patient outcomes through early intervention and targeted therapy. For instance, in 2023, according to the UK Health Security Agency, a UK-based government agency, the incidence of yeast-related bloodstream infections across England increased by 4% compared to 2022. Therefore, the rising prevalence of infectious diseases is propelling the growth of the direct-from-blood pathogen detection market.

Key companies operating in the direct-from-blood pathogen detection market are focusing on developing innovative solutions such as unbiased shotgun metagenomic pathogen detection assays to enable comprehensive, culture-independent identification of a broad range of pathogens directly from blood samples for faster and more accurate diagnosis of bloodstream infections. An unbiased shotgun metagenomic pathogen detection assay refers to a sequencing-based diagnostic method that examines all genetic material in a sample without prior pathogen targeting to identify known and novel infectious agents in a single analysis. For example, in February 2026, MedGenome Labs Limited, an India-based health tech company, launched MetaSeq, a metagenomic next-generation sequencing (NGS) blood test capable of detecting over 1,400 pathogens, including bacteria, fungi, parasites, and DNA viruses, from a single sample. This culture-free technology bypasses traditional blood culture limitations, delivering results in about five days to enable faster, targeted treatment for bloodstream infections, especially in immunocompromised patients.

In June 2025, bioMerieux SA, a France-based in vitro diagnostics company, acquired Day Zero Diagnostics Inc. for an undisclosed amount. With this acquisition, bioMerieux intends to bolster its capabilities in infectious disease diagnostics by integrating Day Zero Diagnostics' cutting-edge genome sequencing and bioinformatics technologies to speed up pathogen identification and antimicrobial resistance detection, thereby improving clinical decision-making and patient outcomes. Day Zero Diagnostics Inc. is a US-based diagnostics company providing direct-from-blood pathogen detection technologies.

Major companies operating in the direct-from-blood pathogen detection market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson Company, Illumina Inc., Charles River Laboratories, Hologic Inc., BIOMERIEUX, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Fluxergy Inc., Q-linea AB, DNAe Group, Karius Inc., T2 Biosystems Inc., Spectral Platforms Inc., BOA Biomedical, Deepull Diagnostics S.L.

North America was the largest region in the direct-from-blood pathogen detection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the direct-from-blood pathogen detection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the direct-from-blood pathogen detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct-from-blood pathogen detection market consists of revenues earned by entities by providing services such as rapid pathogen identification, antimicrobial susceptibility testing (AST), whole-genome sequencing analysis, data interpretation and reporting, and outbreak monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-from-blood pathogen detection market also includes sales of nucleic acid extraction reagents, sequencing consumables, blood sample enrichment devices, automated sample preparation instruments, and microfluidic cartridges. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct-From-Blood Pathogen Detection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses direct-from-blood pathogen detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for direct-from-blood pathogen detection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The direct-from-blood pathogen detection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Technology: Polymerase Chain Reaction (PCR)-Based; Next-Generation Sequencing; Immunoassay; Mass Spectrometry; Other Technologies
• 2) By Pathogen Type: Bacterial; Viral; Fungal; Parasitic
• 3) By Application: Sepsis; Bloodstream Infections; Hospital-Acquired Infections; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End Users
• Subsegments:
• 1) By Polymerase Chain Reaction (PCR)-Based: Real-Time Polymerase Chain Reaction (qPCR); Digital Polymerase Chain Reaction (PCR); Multiplex Polymerase Chain Reaction (PCR)
• 2) By Next-Generation Sequencing: Whole Genome Sequencing; Targeted Sequencing
• 3) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA); Lateral Flow Assays; Western Blot
• 4) By Mass Spectrometry: Matrix-Assisted Laser Desorption or Ionization Time-of-Flight Mass Spectrometry; Liquid Chromatography-Tandem Mass Spectrometry
• 5) By Other Technologies: Electrochemical Biosensors; Optical Biosensors; Microfluidic Chips
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton; Dickinson Company; Illumina Inc.; Charles River Laboratories; Hologic Inc.; BIOMERIEUX; Bruker Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Fluxergy Inc.; Q-linea AB; DNAe Group; Karius Inc.; T2 Biosystems Inc.; Spectral Platforms Inc.; BOA Biomedical; Deepull Diagnostics S.L.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Direct-From-Blood Pathogen Detection Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Direct-From-Blood Pathogen Detection Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Direct-From-Blood Pathogen Detection Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Direct-From-Blood Pathogen Detection Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption of Rapid PCR-Based Diagnostics
  • 4.2.2 Increasing Use of Next-Generation Sequencing for Pathogen Detection
  • 4.2.3 Expansion of Mass Spectrometry Applications in Clinical Labs
  • 4.2.4 Growing Implementation of Immunoassay-Based Detection Systems
  • 4.2.5 Rising Focus on Microfluidic and Biosensor Technologies

5. Direct-From-Blood Pathogen Detection Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Research Institutes
• 5.4 Clinical Laboratories
• 5.5 Pharmaceutical And Biotech Companies

6. Direct-From-Blood Pathogen Detection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Direct-From-Blood Pathogen Detection Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Direct-From-Blood Pathogen Detection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Direct-From-Blood Pathogen Detection Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Direct-From-Blood Pathogen Detection Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Direct-From-Blood Pathogen Detection Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Direct-From-Blood Pathogen Detection Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Direct-From-Blood Pathogen Detection Market Segmentation

• 9.1. Global Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction (PCR)-Based, Next-Generation Sequencing, Immunoassay, Mass Spectrometry, Other Technologies
• 9.2. Global Direct-From-Blood Pathogen Detection Market, Segmentation By Pathogen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bacterial, Viral, Fungal, Parasitic
• 9.3. Global Direct-From-Blood Pathogen Detection Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sepsis, Bloodstream Infections, Hospital-Acquired Infections, Other Applications
• 9.4. Global Direct-From-Blood Pathogen Detection Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
• 9.5. Global Direct-From-Blood Pathogen Detection Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR)-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Real-Time Polymerase Chain Reaction (qPCR), Digital Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR)
• 9.6. Global Direct-From-Blood Pathogen Detection Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Whole Genome Sequencing, Targeted Sequencing
• 9.7. Global Direct-From-Blood Pathogen Detection Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA), Lateral Flow Assays, Western Blot
• 9.8. Global Direct-From-Blood Pathogen Detection Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Matrix-Assisted Laser Desorption or Ionization Time-of-Flight Mass Spectrometry, Liquid Chromatography-Tandem Mass Spectrometry
• 9.9. Global Direct-From-Blood Pathogen Detection Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Electrochemical Biosensors, Optical Biosensors, Microfluidic Chips

10. Direct-From-Blood Pathogen Detection Market Regional And Country Analysis

• 10.1. Global Direct-From-Blood Pathogen Detection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Direct-From-Blood Pathogen Detection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Direct-From-Blood Pathogen Detection Market

• 11.1. Asia-Pacific Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Direct-From-Blood Pathogen Detection Market

• 12.1. China Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Direct-From-Blood Pathogen Detection Market

• 13.1. India Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Direct-From-Blood Pathogen Detection Market

• 14.1. Japan Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Direct-From-Blood Pathogen Detection Market

• 15.1. Australia Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Direct-From-Blood Pathogen Detection Market

• 16.1. Indonesia Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Direct-From-Blood Pathogen Detection Market

• 17.1. South Korea Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Direct-From-Blood Pathogen Detection Market

• 18.1. Taiwan Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Direct-From-Blood Pathogen Detection Market

• 19.1. South East Asia Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Direct-From-Blood Pathogen Detection Market

• 20.1. Western Europe Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Direct-From-Blood Pathogen Detection Market

• 21.1. UK Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Direct-From-Blood Pathogen Detection Market

• 22.1. Germany Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Direct-From-Blood Pathogen Detection Market

• 23.1. France Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Direct-From-Blood Pathogen Detection Market

• 24.1. Italy Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Direct-From-Blood Pathogen Detection Market

• 25.1. Spain Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Direct-From-Blood Pathogen Detection Market

• 26.1. Eastern Europe Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Direct-From-Blood Pathogen Detection Market

• 27.1. Russia Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Direct-From-Blood Pathogen Detection Market

• 28.1. North America Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Direct-From-Blood Pathogen Detection Market

• 29.1. USA Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Direct-From-Blood Pathogen Detection Market

• 30.1. Canada Direct-From-Blood Pathogen Detection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Direct-From-Blood Pathogen Detection Market

• 31.1. South America Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Direct-From-Blood Pathogen Detection Market

• 32.1. Brazil Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Direct-From-Blood Pathogen Detection Market

• 33.1. Middle East Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Direct-From-Blood Pathogen Detection Market

• 34.1. Africa Direct-From-Blood Pathogen Detection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Direct-From-Blood Pathogen Detection Market, Segmentation By Technology, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Direct-From-Blood Pathogen Detection Market Regulatory and Investment Landscape

36. Direct-From-Blood Pathogen Detection Market Competitive Landscape And Company Profiles

• 36.1. Direct-From-Blood Pathogen Detection Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Direct-From-Blood Pathogen Detection Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Direct-From-Blood Pathogen Detection Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Becton Dickinson Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Direct-From-Blood Pathogen Detection Market Other Major And Innovative Companies

• Charles River Laboratories, Hologic Inc., BIOMERIEUX, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Fluxergy Inc., Q-linea AB, DNAe Group, Karius Inc., T2 Biosystems Inc., Spectral Platforms Inc., BOA Biomedical, Deepull Diagnostics S.L.

38. Global Direct-From-Blood Pathogen Detection Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Direct-From-Blood Pathogen Detection Market

41. Direct-From-Blood Pathogen Detection Market High Potential Countries, Segments and Strategies

• 41.1 Direct-From-Blood Pathogen Detection Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Direct-From-Blood Pathogen Detection Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Direct-From-Blood Pathogen Detection Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer